Here are a few studies on endometrial cancer. Be sure to check my Disparities and Equity research post for those studies related to endometrial cancer.
Phase 2, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor (ER) Positive Recurrent or Persistent Endometrial Cancer – Konstantinopoulos
EGFL6 is an Important Growth Factor Involved in Endometrial Cancer Tumorigenesis – A. Garrett
#SGOmtg Dr Garrett : EGFL6 over expressed in endometrial cancer , does it have a role in obesity ( mouse study) ?— Dee Sparacio (@womenofteal) March 19, 2022
EGFL6 Signals MAPK pathway .
EGFL6 Promotes endometrial cancer and may be a target for treatment. #gyncsm
SIENDO/ENGOT-EN5/GOG-3055: A Randomized Phase 3 trial of Maintenance Selinexor Versus Placebo after Combination Platinum-Based Chemotherapy in Advanced or Recurrent Endometrial Cancer – Vergote
Ipatasertib, an Oral AKT Inhibitor, in Combination with Bevacizumab Exhibits Anti-Tumorigenic Effects in Pre-clinical Studies for Endometrioid Endometrial Cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium – M. Newton
In Vivo and In Vitro Efficacy of Enhertu in Uterine Serous Carcinoma – Speaker: L. Mutlu